Taxotere MDL Litigation Liaison Counsel Appointed

Taxotere Hair Loss Litigation
Attorney Pamela A. Borgess, the founder of Borgess Law, LLC, is an experienced trial attorney who focuses on civil litigation, including defective medical drugs/devices cases. For more information about the Taxotere lawsuits or to discuss a potential claim, contact Borgess Law at (567) 455-5955 or toll-free at (844) LAW-9144. You can also contact Borgess Law by submitting an online inquiry. Borgess Law never charges for initial consultations.

On November 17, 2016, the Judge handling the Taxotere (Docetaxel) Products Liability Litigation (MDL 2740) issued Pretrial Order No. 2 appointing counsel as Plaintiffs’ Liaison Counsel, Defendants’ Liaison Counsel and to the Plaintiffs’ Steering Committee. All appointments are for a 1 year term beginning immediately until January 1, 2018. Applications for the subsequent term must be...

Read More

Louisiana Federal Court Consents to Assignment of the Taxotere Hair-Loss Litigation

Taxotere Hair Loss Litigation

On October 3, 2016, the U.S. District Court for the Eastern District of Louisiana consented to assignment of the actions alleging that the chemotherapy drug, Taxotere, can cause permanent hair loss, particularly in those being treated for breast cancer, to the Honorable Lance M. Africk for coordinated or consolidated pretrial proceedings. As previously reported in...

Read More

TAXOTERE PERMANENT HAIR LOSS LAWSUITS COULD BECOME AN MDL (MULTIDISTRICT LITIGATION)

Medical Drug Safety

On July 22, a motion was filed requesting a new multidistrict litigation (MDL) for lawsuits alleging that Sanofi SA’s chemotherapy drug, Taxotere, can cause permanent hair loss, particularly in those being treated for breast cancer. Multidistrict litigation is a special procedure in which federal civil (noncriminal) cases from around the country are transferred to one...

Read More

Taxotere® Litigation: Ohio Breast Cancer Survivor Now Takes On Sanofi-Aventis

Pharmaceutical litigation

Temporary hair loss following chemotherapy is hard enough. Unfortunately, as acknowledged by the FDA, cases of permanent hair loss (alopecia) have been reported in patients who have been given the chemotherapy drug, Taxotere®. Now a breast cancer survivor from Ohio, Hattie Carson, has decided to take on Sanofi-Aventis in Ohio Federal Court. According to her complaint, Ms. Carson underwent...

Read More